Answers are grounded in this paper and cite their sources.
Retrospective review presents 10 PPF cases and highlights successful interventions like ERCP and pancreatic stenting.
Background: Pancreatic pleural fistula (PPF) is a rare complication of chronic pancreatitis, leading to recurrent, large pleural effusions rich in amylase. Due to its nonspecific presentation, diagnosis is frequently delayed. Objective:To present a 10-patient case series of PPF managed at our institution and review the literature on diagnostic and therapeutic strategies. Methods: A retrospective review was conducted of 10 patients diagnosed with PPF between January 2021 and March 2024. Data collected included clinical features, imaging findings, interventions (conservative, endoscopic, surgical), and outcomes over a 6–18 month follow-up period. Results: All patients had massive left-sided pleural effusions with pleural fluid amylase >10,000 IU/L. MRCP/ERCPconfirmed pancreatic duct disruption in 8 patients. ERCPwith pancreatic stenting was successful in 7/8 cases. Two patients were managed conservatively. One patient required distal pancreatectomy after failed endoscopic management. Conclusion: PPF should be suspected in patients with recurrent pleural effusion and history of pancreatitis. Endoscopic therapy with pancreatic duct stenting is safe and effective. Surgery should be reserved for refractory cases.
No takes yet. Share an insight, caveat, or question.
Jhala et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: